$CEVA

CEVA (NASDAQ: CEVA) executive may sell 51,512 shares

CEVA (NASDAQ: CEVA) officer Michael Boukaya filed a notice to sell up to 51,512 shares of CEVA common stock, valued at $1,528,361, through Oppenheimer & Co. Inc. on Nasdaq, with sales expected around 08/19/2026. The shares stem from prior vesting of restricted stock units (RSUs).

Original reporting
Published Aug 20, 2026, 10:40 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CEVA
Bearish
medium confidence
Mentioned
$CEVA
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CEVABearishLow
01

Why it matters

The disclosed sale could lead to short‑term price weakness if the market anticipates increased supply, but the modest amount limits broader impact.

02

Market read

Primary insider sale filing; modest size, limited trading relevance.

03

What to watch

Potential that the shares will be sold gradually, reducing immediate pressure.

Relevance 4/10Novelty 4/10Timing: sale planned for 08/19/2026

Background

Form 144 filings disclose planned sales of restricted securities by insiders, signaling possible future supply.

Company-level read

Ticker impact

$CEVABearishMedium confidence
Context

Officer Michael Boukaya filed a Form 144 to sell up to 51,512 CEVA shares worth $1.53 M.

Expected impact

Small downward pressure if shares hit the market.

Evidence & confidence

The filing is a primary disclosure of insider intent; size is modest but may affect short‑term liquidity.

Market effects

Minimal; CEVA operates in the semiconductor IP space, no sector‑wide impact.

None; the filing is company‑specific.

Low; limited to CEVA shareholders.

Counterpoint

The sale size is small relative to float; price impact may be negligible.

Key entities

  • Michael Boukaya

    CEVA executive filing the Form 144.

Related articles

$CEVAMedAI 8/10

CEVA (CEVA) Q2 2026 Earnings Call Transcript

CEVA, Inc. reported Q2 2026 results: total revenue rose 13% to $29 million, with licensing and related revenue up 21% to $18.2 million and royalty revenue up 17% sequentially to $10.8 million. Non-GAAP operating income was $3.1 million, non-GAAP net income $2.3 million, and non-GAAP diluted EPS $0.08. CEVA raised FY2026 revenue guidance to 13% to 15% growth and Q3 revenue to $30.5m to $34.5m.

$CEVAMedAI 8/10

Ceva, Inc. Announces Second Quarter 2026 Financial Results

Ceva, Inc. (NASDAQ: CEVA) reported Q2 2026 results for the quarter ended June 30. Total revenue rose 13% to $29.0 million. Licensing and related revenue increased 21% to $18.2 million, highest in three years, and royalty revenue was $10.8 million. Non-GAAP operating income was $3.1 million (11% margin), versus $0.8 million (3%) a year earlier.

$CEVAHighAI 8/10

Ceva Q2 Earnings Call Highlights

CEVA management said baseband subsystem offerings exclude RF technology and can increase licensing deal sizes and royalties. CEVA reported 567 million CEVA-powered device shipments (+16% QoQ), with mobile modem shipments at 61 million and cellular IoT at 68 million. GAAP gross margin was 87%, GAAP operating loss narrowed to $2.1M, and CEVA raised FY2026 revenue growth to 13% to 15%.

$CEVAMed

CEVA INC (CEVA): Results of Operations and Financial Condition

CEVA INC (CEVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_1001319.htm EXHIBIT 99.1 ex_1001319.htm Exhibit 99.1 Ceva, Inc. Announces Second Quarter 2026 Financial Results Company posts highest licensing and related revenues in three years on strong AI and connectivity demand ROCKVILLE, MD., August 10, 2026 – Ceva, Inc. (NASD